Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

European Journal of Nuclear Medicine

Volumn 28, Issue 4, 2001, Pages 426-434

  Paganelli, Giovanni ^a   Zoboli, Stefania ^a   Cremonesi, Marta ^a   Bodei, Lisa ^a   Ferrari, Mahila ^a   Grana, Chiara ^a   Bartolomei, Mirco ^a   Orsi, Franco ^a   De Cicco, Concetta ^a   Mäcke, Helmut R ^b   Chinol, Marco ^a   De Braud, Filippo ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

90Y 111In DOTATOC; Peptides; Receptor mediated radiotherapy; Somatostatin analogue

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ALPHA INTERFERON; INDIUM 111; OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE 1,4,7,10 TETRAAZACYCLODECANE 1,4,7,10 TETRAACETIC ACID YTTRIUM 90]; OCTREOTIDE[3 TYROSINE]; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; YTTRIUM 90;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; MULTICENTER STUDY; NEPHROTOXICITY; SCINTILLATION CAMERA; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; INDICATORS AND REAGENTS; MALE; MIDDLE AGED; NEOPLASMS; OCTREOTIDE; RADIOMETRY; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 0035094321     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100490     Document Type: Article

References (30)

1. 3]-octreotide: The Rotterdam experience with more than 1000 patients
2. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors
3. Somatostatin-receptor scintigraphy in primary breast cancer
4. Radiolabelled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy
5. Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer
6. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels
7. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995)
8. 111In-pentetreotide
9. DOTATOC - A new powerful tool for receptor-mediated radionuclide therapy
10. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
11. 3]octreotide, a promising somatostatin analogue for radionuclide therapy
12. 3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy
13. Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy
14. 90Y-DOTATOC
15. 111In-DTPA-octreotide in the same patients: Biodistribution, kinetics, organ and tumor uptake
16. 1] octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumours: Synthesis, radiolabelling and in vitro validation
17. 90Y-conjugates: The IEO experience
18. Developing and testing integrated multi-compartment models to describe a single-input multiple-output study using the SAAM II software system
19. Indium-111-DOTA-lanreotide: Biodistribution, safety and radiation absorbed dose in tumour patients
20. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine
21. Reporting results of cancer treatment
22. Clinical radiation nephropathy
23. Radiation-induced splenic atrophy in patients with Hodgkin's disease and non-Hodgkin's lymphomas
24. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro
25. Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes
26. Late onset of renal dysfunction in survivors of bone marrow transplantation
27. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships
28. Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue
29. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: Improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry
30. Yttrium-90 DOTATOC: First clinical results